Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP414386.RAOtHGPccwLkwMTEMCfB375B08HzCa_Theyo_MHE-2ag4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP414386.RAOtHGPccwLkwMTEMCfB375B08HzCa_Theyo_MHE-2ag4130_assertion type Assertion NP414386.RAOtHGPccwLkwMTEMCfB375B08HzCa_Theyo_MHE-2ag4130_head.
- NP414386.RAOtHGPccwLkwMTEMCfB375B08HzCa_Theyo_MHE-2ag4130_assertion description "[This study describes the use of DHPLC for mutation analysis for BRCA1, BRCA2 and CHEK2 (1100delC) in 22 patients with a family history of breast and/or ovarian cancer and early onset breast cancer (<35 years of age).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414386.RAOtHGPccwLkwMTEMCfB375B08HzCa_Theyo_MHE-2ag4130_provenance.
- NP414386.RAOtHGPccwLkwMTEMCfB375B08HzCa_Theyo_MHE-2ag4130_assertion evidence source_evidence_literature NP414386.RAOtHGPccwLkwMTEMCfB375B08HzCa_Theyo_MHE-2ag4130_provenance.
- NP414386.RAOtHGPccwLkwMTEMCfB375B08HzCa_Theyo_MHE-2ag4130_assertion SIO_000772 14507240 NP414386.RAOtHGPccwLkwMTEMCfB375B08HzCa_Theyo_MHE-2ag4130_provenance.
- NP414386.RAOtHGPccwLkwMTEMCfB375B08HzCa_Theyo_MHE-2ag4130_assertion wasDerivedFrom befree-2016 NP414386.RAOtHGPccwLkwMTEMCfB375B08HzCa_Theyo_MHE-2ag4130_provenance.
- NP414386.RAOtHGPccwLkwMTEMCfB375B08HzCa_Theyo_MHE-2ag4130_assertion wasGeneratedBy ECO_0000203 NP414386.RAOtHGPccwLkwMTEMCfB375B08HzCa_Theyo_MHE-2ag4130_provenance.